Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
Reset 

AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALS

Read more ››
By: GlobeNewswire - 26 Feb 2024
Related companies:  AB Science SA | AllianceBernstein L.P.

Brain Canada launches Season 3 of Playing with Marbles podcast – inside youth mental health

Read more ››
By: GlobeNewswire - 26 Feb 2024
Related companies:  Brain Canada Foundation

TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Nanjing TransThera Biosciences Co.,Ltd.

OVER HALF OF AUSTRALIAN WOMEN FEEL THEIR PAIN IS IGNORED OR DISMISSED - HIGHLIGHTING NATIONAL GENDER PAIN GAP

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  GC Biopharma Corp.

Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Coeptis Therapeutics Inc

Cure Brain Cancer Foundation CEO Lance Kawaguchi Completes SouthPoleTrek4Cancer, Raises Over $1 Million for Cancer Research

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Cure Brain Cancer Foundation

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Pfizer Limited, Sandwich | Pfizer Limited

SIGMA LITHIUM CEO TO PRESENT AT 2024 BMO MINING CONFERENCE; LOW PRODUCTION COSTS REFLECTED IN GUIDANCE OF CIF CHINA CASH OPERATING COSTS OF $510/t

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

UnitedRx Showcases Innovative Pharmacy Solutions Nationwide

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Equitable Breakthroughs in Medicine Development Reaches Next Phase Driving Diversity in Clinical Trials in Georgia, South Carolina, Tennessee, and Texas

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Compugen to Present at the Leerink Partners Global Biopharma Conference 2024

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Syndax Announces Participation at Two Upcoming Investor Conferences

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Syndax Pharmaceuticals, Inc.

Dr. Harden-Mack Leads at Quantum Leap Summit, Advocates Holistic Wellness

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Spyre Therapeutics to Participate in the 44th Annual TD Cowen Health Care Conference

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Spyre Therapeutics, Inc.

GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  GE HealthCare Technologies Inc.

Boston IVF Named the #1 Physician Practice for Top Fertility Doctors in Massachusetts

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024

Actinium Announces Iomab-B Markedly Increases Long Term Survival in Patients 65 Years or Older with Active Relapsed or Refractory AML in the Phase 3 SIERRA Trial at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT®

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
Related companies:  Actinium Pharmaceuticals, Inc.

GeminiBio launches human serum AB product for global cell therapy market

Read more ››
By: PR Newswire Association LLC. - 26 Feb 2024
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
to the top ↑